Stocks

Annovis Bio Inc

ANVSNYSEUSDHealthcare

About Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Ticker
ANVS
Trading on
NYSE
ISIN
-
Industry
Biotechnology
Sector
Healthcare
CEO
Dr. Maria L. Maccecchini Ph.D.
Headquarters
101 Lindenwood Drive, Malvern, PA, United States, 19355
Employees
7
Website
annovisbio.com

Metrics

Market cap$39.8M
P/E ratio-
EPS-$1.75
Dividend Yield0.00%
Beta1.35
Forward P/E ratio0
EBIDTA-
Ex dividend date-

Analyst Insights & forecasts

Buy100%
Hold0%
Sell0%

Based on information from 4 analysts.

Average price target$10.50

Earnings per share (EPS) forecast

Q4 • 25Q1 • 26Q2 • 26
Actual-$0.39-$0.63-$0.40
Expected-$0.31-$0.35-$0.44
Surprise-25.81%-80.00%9.09%
MissedMissedCurrent

Financial Performance

Q2 • 26Q3 • 26QoQ growth
Revenue$0M-NaN%
Net income$-14.8M$-9.46B63,743.56%
Profit margin-∞%0.00%0.00%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

FAQs

01How much is a Annovis Bio Inc share?

Annovis Bio Inc shares are currently traded for undefined per share.

02How many shares does Annovis Bio Inc have?

Annovis Bio Inc currently has 43M shares.

03Does Annovis Bio Inc pay dividends?

No, Annovis Bio Inc doesn't pay dividends.

04What is Annovis Bio Inc 52 week high?

Annovis Bio Inc 52 week high is $5.50.

05What is Annovis Bio Inc 52 week low?

Annovis Bio Inc 52 week low is $0.62.

06What is the 200-day moving average of Annovis Bio Inc?

Annovis Bio Inc 200-day moving average is $1.81.

07Who is Annovis Bio Inc CEO?

The CEO of Annovis Bio Inc is Dr. Maria L. Maccecchini Ph.D..

08How many employees Annovis Bio Inc has?

Annovis Bio Inc has 7 employees.

09What is the market cap of Annovis Bio Inc?

The market cap of Annovis Bio Inc is $39.8M.

10What is the P/E of Annovis Bio Inc?

The current P/E of Annovis Bio Inc is null.

11What is the EPS of Annovis Bio Inc?

The EPS of Annovis Bio Inc is -$1.75.

12What is the PEG Ratio of Annovis Bio Inc?

The PEG Ratio of Annovis Bio Inc is null.

13What do analysts say about Annovis Bio Inc?

According to the analysts Annovis Bio Inc is considered a buy.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.